Asia-Pacific Active Pharmaceutical Ingredient Market Analysis 2012-2017 and Forecast 2018-2023

SKU ID : 99ST- 11153075

Publishing Date : 14-Mar-2018

No. of pages : 160

PRICE
3300
6600

  • Snapshot
    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
    The Asia-Pacific Active Pharmaceutical Ingredient market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredient by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
    Synthetic API
    Biotech API
    Others



    Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy’s Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine
    Biocon
    Johnson Matthey
    Hisun Pharmacy
    Cambrex
    Shandong Xinhua Pharmaceutical
    Lonza group
    Huahai Pharmaceutical
    Haerbin Pharmaceutical Group
    Cipla
    Tian Yao
    Lupin
    North East Pharmaceutical
    Albemarle
    Shandong Lukang Pharmaceutical
    Jiangsu Hengrui Medicine
    Bachem
    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
    Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    Oncology Drugs
    Anti-diabetic Drugs
    Cardiovascular Drugs
    Central Nervous System Drugs (CNS Drugs)
    Musculoskeletal Drugs
    Other Drugs
    Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
    China
    Japan & Korea
    India
    Southeast Asia
    Oceania

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports